http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101508413-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101508413-B1 |
| titleOfInvention | Chimeric mesenchymal stem cell population and process for preparing the same |
| abstract | The present invention relates to a method for producing a chimeric mesenchymal stem cell group comprising mixing cultured mesenchymal stem cells derived from a donor tissue obtained from a different donor, a chimeric mesenchymal stem cell group prepared by the method, a chimeric mesenchymal stem A method for producing a chimeric mesenchymal stem cell group having improved ability to proliferate comprising the step of freezing and thawing a cell group, a method for differentiating the chimeric mesenchymal stem cell group having improved proliferation performance, a method for differentiating the chimeric mesenchymal stem cell group, The present invention relates to a method for culturing a mesenchymal stem cell obtained from a donor and a cytotoxic agent obtained from a donor, and a cell treatment agent containing stem cells isolated from the mesenchymal stem cell group or cells differentiated therefrom as an active ingredient. Since the chimeric mesenchymal stem cell group of the present invention can be produced from differentiated tonsil tissues as well as from a discolored tonsil tissue, it can be produced economically and exhibits activity as the same stem cell after freezing and thawing, It could be used as a bank's cell source. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10870830-B2 |
| priorityDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 458.